Search research articles
Contact Us
Filters
Showing results (81-90 of 112) with videos related to
Page
of 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1995
Formation of cytosine arabinoside-5'-triphosphate in different cultured lymphoblastic leukaemic cells with reference to their drug sensitivity
U Köhl, D Schwabe, E Montag, et al.
The Journal of Antimicrobial Chemotherapy
|
February 14, 1998
Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer
A H Groll, G Just-Nuebling, M Kurz, et al.
Anticancer Research
|
May 16, 2000
Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs
J Cinatl, J Cinatl, R Kotchetkov, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
MIBG-treatment in neuroblastoma; experiences of the Tübingen/Frankfurt group
J Treuner, V Gerein, T Klingebiel, et al.
Leukemia
|
August 19, 2005
Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia
T Lehrnbecher, T Bernig, M Hanisch, et al.
Medical and Pediatric Oncology
|
January 1, 1991
Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the German Neuroblastoma Trial
T Klingebiel, F Berthold, J Treuner, et al.
Cancer Research
|
January 27, 1998
Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells
J Cinatl, J Cinatl, J U Vogel, et al.
Bone Marrow Transplantation
|
July 27, 2005
Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients
K Bochennek, C Andreas, C Margraf, et al.
Klinische Padiatrie
|
May 1, 1986
[Initial experiences in the treatment of children with metastatic and recurrent neuroblastoma using meta-iodobenzylguanidine]
T Klingebiel, U Feine, D Niethammer, et al.
Klinische Padiatrie
|
March 2, 2012
Impact of minimal residual disease detection prior to autologous stem cell transplantation for post-transplant outcome in high risk neuroblastoma
K Bochennek, R Esser, T Lehrnbecher, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 112) with videos related to
Sort By:
Page
of 12
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1995
Formation of cytosine arabinoside-5'-triphosphate in different cultured lymphoblastic leukaemic cells with reference to their drug sensitivity
U Köhl, D Schwabe, E Montag, et al.
The Journal of Antimicrobial Chemotherapy
|
February 14, 1998
Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer
A H Groll, G Just-Nuebling, M Kurz, et al.
Anticancer Research
|
May 16, 2000
Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs
J Cinatl, J Cinatl, R Kotchetkov, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
MIBG-treatment in neuroblastoma; experiences of the Tübingen/Frankfurt group
J Treuner, V Gerein, T Klingebiel, et al.
Leukemia
|
August 19, 2005
Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia
T Lehrnbecher, T Bernig, M Hanisch, et al.
Medical and Pediatric Oncology
|
January 1, 1991
Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the German Neuroblastoma Trial
T Klingebiel, F Berthold, J Treuner, et al.
Cancer Research
|
January 27, 1998
Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells
J Cinatl, J Cinatl, J U Vogel, et al.
Bone Marrow Transplantation
|
July 27, 2005
Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients
K Bochennek, C Andreas, C Margraf, et al.
Klinische Padiatrie
|
May 1, 1986
[Initial experiences in the treatment of children with metastatic and recurrent neuroblastoma using meta-iodobenzylguanidine]
T Klingebiel, U Feine, D Niethammer, et al.
Klinische Padiatrie
|
March 2, 2012
Impact of minimal residual disease detection prior to autologous stem cell transplantation for post-transplant outcome in high risk neuroblastoma
K Bochennek, R Esser, T Lehrnbecher, et al.
Page
of 12